Nuclear Rad51 foci induced by DNA damage are distinct from Rad51 foci associated with B cell activation and recombination

被引:17
|
作者
Li, MJ
Maizels, N
机构
[1] Yale Univ, Dept Biochem & Mol Biophys, New Haven, CT 06520 USA
[2] Yale Univ, Dept Genet, New Haven, CT 06520 USA
关键词
D O I
10.1006/excr.1997.3761
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lipopolysaccharide (LPS) is a B cell mitogen which can stimulate murine primary B cells to proliferate and carry out immunoglobulin heavy chain class switch recombination. LPS can also function as an endotoxin, which may cause DNA damage and apoptosis in certain types of cells. We have previously reported that LPS-activated primary murine B cells contain nuclear foci that stain brightly with anti-Rad51 antibodies (Li ct al. (1996) Proc. Natl. Acad. Sci. USA 93, 10222-10227). We have near analyzed Rad51 nuclear foci induced in both primary and immortalized B cells by treatment with the DNA damaging agent, methyl methanesulfonate (MMS). We have found that, in LPS-cultured primary B cells, MMS treatment increases the fraction of cells containing Rad51 foci and induces formation of a very high number of foci per cell. The foci induced by RIMS treatment are small, punctate, and numerous; in contrast, the foci induced by LPS activation are large, brightly staining, and relatively few in number. In LPS-cultured primary B cells, Rad51 relocalizes during the cell cycle, and large, brightly staining nuclear foci are present in only restricted stages of the cell cycle. Rad51 foci similar to those present in LPS-activated primary B cells are also observed in immortalized B cell lines cultured in the absence of LPS. These foci are unaltered in number or appearance by culture with LPS, but treatment of immortalized B cell lines with MMS induces foci which are small and punctate in staining, like those induced by MMS in primary B cells. These data show that distinctive Rad51 foci are induced by DNA damaging agents and cell activation and that the response to DNA damage mag involve pathways distinct from those associated with B cell activation and switch recombination. (C) 1997 Academic Press.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 50 条
  • [41] Interaction of human recombination proteins Rad51 and Rad54
    Golub, EI
    Kovalenko, OV
    Gupta, RC
    Ward, DC
    Radding, CM
    NUCLEIC ACIDS RESEARCH, 1997, 25 (20) : 4106 - 4110
  • [42] RAD51 RING TRIAL: A EUROPEAN INTERLABORATORY ANALYTICAL VALIDATION TO DETERMINE THE ROBUSTNESS OF RAD51 AS A BIOMARKER FOR HOMOLOGOUS RECOMBINATION
    Kramer, C.
    Llop-Guevara, A.
    Yaniz-Galende, E.
    Pellegrino, B.
    Ter Haar, N.
    Campanini, N.
    Musolino, A.
    Leary, A.
    Vreeswijk, M.
    Serra, V.
    Bosse, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A333 - A334
  • [43] RAD51 paralog function in replicative DNA damage and tolerance
    Rein, Hayley L.
    Bernstein, Kara A.
    Baldock, Robert A.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2021, 71 : 86 - 91
  • [44] Rad51 accumulation at sites of DNA damage and in postreplicative chromatin
    Tashiro, S
    Walter, J
    Shinohara, A
    Kamada, N
    Cremer, T
    JOURNAL OF CELL BIOLOGY, 2000, 150 (02): : 283 - 291
  • [45] Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51
    Sakamoto, S
    Nishikawa, K
    Heo, SJ
    Coto, M
    Furuichi, Y
    Shimamoto, A
    GENES TO CELLS, 2001, 6 (05) : 421 - 430
  • [46] RAD51 is involved in repair of damage associated with DNA replication in mammalian cells
    Lundin, C
    Schultz, N
    Arnaudeau, C
    Mohindra, A
    Hansen, LT
    Helleday, T
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 328 (03) : 521 - 535
  • [47] Inhibiting homologous recombination by targeting RAD51 protein
    Demeyer, A.
    Benhelli-Mokrani, H.
    Chenais, B.
    Weigel, P.
    Fleury, F.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [48] RAD51 foci in patient-derived ovarian cancer organoids are associated with response to carboplatin and olaparib
    Compadre, Amanda
    van Biljon, Lillian
    Fashemi, Bisiayo
    Graham, Olivia
    Rodriguez, Jeimmy
    Lomonosova, Elena
    Blachut, Barbara
    Kuroki, Lindsay
    McCourt, Carolyn
    Hagemann, Andrea
    Thaker, Premal
    Massad, L.
    Powell, Matthew
    Mutch, David
    Fuh, Katherine
    Khabele, Dineo
    Mullen, Mary
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S308 - S309
  • [49] The Rad51 paralog Rad51B promotes homologous recombinational repair
    Takata, M
    Sasaki, MS
    Sonoda, E
    Fukushima, T
    Morrison, C
    Albala, JS
    Swagemakers, SMA
    Kanaar, R
    Thompson, LH
    Takeda, S
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (17) : 6476 - 6482
  • [50] DNA repair protein RAD51 homolog 1 (RAD51), a potential prognostic biomarker and target for breast cancer
    Tang, Y-Q.
    Yap, W. H.
    Chia, A. Y. Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S235 - S236